""

Acute leukemia / MDS

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

Title: A Double- Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of BL-8040 Addition to Consolidation Therapy in AML Patients
Phase: II
Contact: Diana Six / (Study Nurse)
Clinical Investigator: Prof. Dr. Alwin Krämer
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02502968
EudraCT-Number: siehe EU klinisches Studienregister 2014-002702-21
Title: Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ?65 Years
Phase: III
Contact: Diana Six / (Study Nurse)
Clinical Investigator: Prof. Dr. Carsten Müller-Tidow
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02140242
EudraCT-Number: siehe EU klinisches Studienregister 2013-003191-12

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Care

Title: Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
Phase: II
Contact: Lea Gölz / (Study Nurse)
Clinical Investigator: Prof. Dr. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03989713
EudraCT-Number: Keine Angabe. Nicht-interventionelle Studien oder Studien, die nicht unter das Arzneimittelgesetz fallen, besitzen keine EudraCT-Nummer.

Others

There are currently no studies available